inflammatory breast cancer
Showing 1 - 25 of >10,000
Inflammatory Breast Cancer Trial (Breast conserving surgery, Radical modified mastectomy)
Not yet recruiting
- Inflammatory Breast Cancer
- Breast conserving surgery
- Radical modified mastectomy
- (no location specified)
Nov 14, 2023
Invasive Breast Cancer, Inflammatory Breast Cancer Stage III, HER2-positive Breast Cancer Trial in Boston (Trastuzumab
Not yet recruiting
- Invasive Breast Cancer
- +4 more
- Trastuzumab deruxtecan
- Durvalumab
-
Boston, Massachusetts
- +1 more
Mar 20, 2023
Inflammatory Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast Trial in Boston (Eribulin, Adriamycin,
Active, not recruiting
- Inflammatory Breast Cancer
- Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
- Eribulin
- +2 more
-
Boston, Massachusetts
- +1 more
Nov 28, 2022
Breast Cancer, Inflammatory Breast Cancer Stage IV, Inflammatory Breast Tumors Trial in Knoxville (Self-Administered Hypnosis,
Recruiting
- Breast Cancer
- +4 more
- Self-Administered Hypnosis
- Self-Administered White Noise Hypnosis
-
Knoxville, TennesseeUniversity of Tennessee Knoxville
Sep 26, 2023
Edema, Erythema, Estrogen Receptor Negative Trial in Houston (Laboratory Biomarker Analysis, Pembrolizumab)
Active, not recruiting
- Edema
- +8 more
- Laboratory Biomarker Analysis
- Pembrolizumab
-
Houston, TexasM D Anderson Cancer Center
Jan 23, 2023
Breast Cancer, HER2-positive Breast Cancer, Triple Negative Breast Cancer Trial in Boston (MRI)
Recruiting
- Breast Cancer
- +5 more
- MRI
-
Boston, MassachusettsBrigham and Women's Hospital
Dec 9, 2022
Tumor Biopsy in Creating Research Tissue Registry in
Recruiting
- Inflammatory Breast Carcinoma
- +2 more
- Biospecimen Collection
- +3 more
-
Houston, Texas
- +4 more
Jan 6, 2023
Breast Cancer Trial in Houston (Panitumumab, Nab-paclitaxel, Carboplatin)
Completed
- Breast Cancer
- Panitumumab
- +5 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Sep 20, 2022
Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Breast Inflammatory Carcinoma Trial in
Active, not recruiting
- Anatomic Stage IIIB Breast Cancer AJCC v8
- +4 more
- Pembrolizumab
-
Houston, TexasM D Anderson Cancer Center
Sep 30, 2022
Breast Inflammatory Carcinoma, Recurrent Breast Inflammatory Carcinoma, Stage IV Breast Inflammatory Carcinoma Trial in Houston
Recruiting
- Breast Inflammatory Carcinoma
- +2 more
- Eribulin Mesylate
- Grapiprant
-
Houston, TexasM D Anderson Cancer Center
Jun 27, 2022
Breast Cancer Trial in Boston, Ann Arbor (drug, procedure, radiation)
Metastatic Breast Cancer, Breast Cancer Trial in Houston (Neratinib, Capmatinib)
Not yet recruiting
- Metastatic Breast Cancer
- Breast Cancer
-
Houston, TexasM D Anderson Cancer Center
Feb 16, 2022
Breast Cancer Trial in Bloomington, New York (Nivolumab 360mg, Paclitaxel 80mg/m^2, Doxorubicin 60mg/m^2)
Completed
- Breast Cancer
- Nivolumab 360mg
- +6 more
-
Bloomington, Indiana
- +1 more
Feb 2, 2022
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8
Recruiting
- Anatomic Stage III Breast Cancer AJCC v8
- +12 more
- Carboplatin
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Jun 16, 2022
Anatomic Stage IV Breast Cancer AJCC v8, Breast Inflammatory Carcinoma, Metastatic Triple-Negative Breast Carcinoma Trial in
Not yet recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +3 more
- Carboplatin
- +2 more
-
Chicago, IllinoisNorthwestern University
Oct 13, 2021
Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
Not yet recruiting
- Breast Cancer
- (no location specified)
Jul 18, 2022
Inflammatory Breast Cancer, Invasive Ductal Breast Carcinoma, Invasive Lobular Breast Carcinoma Trial in New Brunswick, Salt
Active, not recruiting
- Inflammatory Breast Cancer
- +9 more
- External beam radiation therapy
-
New Brunswick, New Jersey
- +1 more
Jan 30, 2022
Recurrent Breast Inflammatory Carcinoma, Stage IV Breast Inflammatory Carcinoma Trial in Houston (Atezolizumab, Cobimetinib,
Recruiting
- Recurrent Breast Inflammatory Carcinoma
- Stage IV Breast Inflammatory Carcinoma
- Atezolizumab
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Aug 11, 2021
Breast Cancer Trial in Toronto
Recruiting
- Breast Cancer
-
Toronto, Ontario, CanadaSunnybrook Health Sciences Centre-Odette Cancer Centre
Jan 10, 2023
Individual Radiosensitivity During Radiotherapy for Breast
Recruiting
- Radiation Tolerance
- Breast Neoplasms
- Blood sample
-
Stockholm, SwedenKarolinska University Hospital
Oct 2, 2022
Cancer, Treatment-Related, Tumor of Breast, Systemic Inflammatory Response Trial in Roma (cryoablation)
Completed
- Cancer, Treatment-Related
- +3 more
- cryoablation
-
Roma, ItalySapienza University of Rome
Feb 13, 2023
Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8
Active, not recruiting
- Anatomic Stage IIB Breast Cancer AJCC v8
- +19 more
-
Gilbert, Arizona
- +4 more
Dec 6, 2022